Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on July 14, 2025

Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR | MarketsandMarkets™.

Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR | MarketsandMarkets™.

Delray Beach, FL, July 14, 2025 (GLOBE NEWSWIRE) -- The global derma fillers market, valued at US$3.74 billion in 2024 stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted …

Ciao Bella! Euro Summer Starts Right Here in Canada at Chopped Leaf

Ciao Bella! Euro Summer Starts Right Here in Canada at Chopped Leaf

Oakville, Ontario, Canada, July 14, 2025 (GLOBE NEWSWIRE) -- OAKVILLE, ON – Fresh, light and full of flavour, Chopped Leaf is introducing two new low-calorie, summer-fresh salads: the Antipasto Salad and Peach Caprese Salad, available across Canada …

CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors

CompoSecure Enhances Board of Directors with the Appointment of Two Additional Independent Directors

SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of two new members to its Board of Directors (“Board”). Effective …

Disc Medicine Appoints Nadim Ahmed to its Board of Directors

Disc Medicine Appoints Nadim Ahmed to its Board of Directors

WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …

Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform

Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform

Washington, D.C, July 14, 2025 (GLOBE NEWSWIRE) -- As Bitcoin surged over 300% between 2020 and 2023, digital assets have moved from speculative bets to a central pillar of modern finance. Billionaires like Elon Musk and Michael Saylor, and institutions …

Pilot Light Unveils Updated Food Education Standards to Transform How Students Learn Through Food

Pilot Light Unveils Updated Food Education Standards to Transform How Students Learn Through Food

Chicago, July 14, 2025 (GLOBE NEWSWIRE) -- Pilot Light today announced the release of its updated Food Education Standards, the first-ever comprehensive framework for integrating Food Education into PreK-12 classrooms. The revised standards build on five …

Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3

Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3

TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …

Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners

Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners

London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …

Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial

Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial

SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real- …

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer

Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer

--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …

MKS Inc. Announces Second Quarter 2025 Earnings Conference Call

MKS Inc. Announces Second Quarter 2025 Earnings Conference Call

ANDOVER, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2025 financial results after market close on …

INSPIRED Launches New Social Media Platform that Brings Together Innovators, Investors and Collaborators to Fuel Purpose-Driven Ideas

INSPIRED Launches New Social Media Platform that Brings Together Innovators, Investors and Collaborators to Fuel Purpose-Driven Ideas

ZÜRICH, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- INSPIRED today announces the launch of its new social media platform where innovators, investors and collaborators can connect to turn world-changing ideas into reality. By empowering purpose-driven …

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)

JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)

IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …

HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines

HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines

VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has received a …

LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership

LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time

DALLAS, July 14, 2025 (GLOBE NEWSWIRE) --  Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …

Rumble Names Ian O’Donnell VP for Rumble Cloud

Rumble Names Ian O’Donnell VP for Rumble Cloud

LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service